Cited by 263Diabetes, Cardiovascular Risks, and LipoproteinsFood composition and propertiesDiabetes Treatment and Management

Improved Plasma Glucose Control, Whole-Body Glucose Utilization, and Lipid Profile on a Low-Glycemic Index Diet in Type 2 Diabetic Men

Open access
Rizkalla, Salwa W., Taghrid, Laika, Laromiguiere, Muriel, Huet, Dorothée, Boillot, Josette, Rigoir, Aude, Elgrably, Fabienne, Slama, Gerard·2004·Diabetes Care

Abstract

OBJECTIVE—To determine whether a chronic low-glycemic index (LGI) diet, compared with a high-glycemic index (HGI) diet, has beneficial effects on plasma glucose control, lipid metabolism, total fat mass, and insulin resistance in type 2 diabetic patients. RESEARCH DESIGN AND METHODS—Twelve type 2 diabetic men were randomly allocated to two periods of 4 weeks of an LGI or HGI carbohydrate diet separated by a 4-week washout interval, in a crossover design. RESULTS—The LGI diet induced lower postprandial plasma glucose and insulin profiles and areas under the curve than after the HGI diet. At the end of the two dietary periods, the 7-day dietary records demonstrated equal daily total energy and macronutrient intake. Body weight and total fat mass were comparable. Four-week LGI versus HGI diet induced improvement of fasting plasma glucose (P < 0.01, Δ changes during LGI vs. HGI), HbA1c (P < 0.01), and whole-body glucose utilization measured by the euglycemic-hyperinsulinemic clamp (P < 0.05). LGI diet induced a decrease in fasting plasma total and LDL cholesterol (Δ changes LGI vs. HGI, P < 0.01), free fatty acids (P < 0.01), apolipoprotein B, and plasminogen activator inhibitor 1 activity. CONCLUSIONS—Only 4 weeks of an LGI diet was able to improve glycemic control, glucose utilization, some lipid profiles, and the capacity for fibrinolysis in type 2 diabetes. Even if changes in glycemic control were modest during the 4-week period, the use of an LGI diet in a longer-term manner might play an important role in the treatment and prevention of diabetes and related disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.27.8.1866

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 42 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Rizkalla, S. W., Taghrid, L., Laromiguiere, M., Huet, D., Boillot, J., Rigoir, A., Elgrably, F., & Slama, G.
Affiliations
  • Inserm (FR)
  • Hôtel-Dieu de Paris (FR)
  • Laboratory of Biochemistry, Hôtel-Dieu Hospital, Paris, France
  • Department of Diabetes, Hôtel-Dieu Hospital, Paris, France
Venue
Diabetes Care
Published
2004-08-01
Volume
27
Issue
8
Pages
1866-1872
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2059885017
Cited by
263
References
42
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 8 · 2021: 10 · 2020: 9 · 2019: 5 · 2018: 7 · 2017: 6 · 2016: 12 · 2015: 12 · 2014: 16 · 2013: 21 · 2012: 18
FWCI
9.54
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Institut National de la Santé et de la Recherche Médicale
  • Université Pierre et Marie Curie
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
low glycemic index diet, high glycemic index diet, type 2 diabetes, glycemic control, postprandial blood glucose, insulin resistance, lipid profile, LDL cholesterol, free fatty acids, apolipoprotein B, plasminogen activator inhibitor-1, fibrinolysis, dietary carbohydrates
MeSH terms
Blood Glucose, Cholesterol, Diabetes Mellitus, Type 2, Dietary Carbohydrates, Fibrinolysis, Glucose, Humans, Lipids, Male, Middle Aged, Triglycerides, Glycemic Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review